Singapore markets close in 6 hours 24 minutes

Huadong Medicine Co., Ltd (000963.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
28.96+0.30 (+1.05%)
As of 10:21AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 50.28B
Enterprise value 48.61B
Trailing P/E 17.04
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.23
Price/book (mrq)2.29
Enterprise value/revenue 1.19
Enterprise value/EBITDA 13.17

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-33.75%
S&P500 52-week change 324.96%
52-week high 346.43
52-week low 327.60
50-day moving average 331.74
200-day moving average 336.03

Share statistics

Avg vol (3-month) 311.33M
Avg vol (10-day) 38.4M
Shares outstanding 51.75B
Implied shares outstanding 61.75B
Float 8730.01M
% held by insiders 158.08%
% held by institutions 111.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.58
Forward annual dividend yield 42.02%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 32.02%
5-year average dividend yield 40.86
Payout ratio 417.24%
Dividend date 3N/A
Ex-dividend date 428 May 2024
Last split factor 21.2:1
Last split date 321 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.20%
Operating margin (ttm)10.53%

Management effectiveness

Return on assets (ttm)6.83%
Return on equity (ttm)13.90%

Income statement

Revenue (ttm)40.92B
Revenue per share (ttm)23.38
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)N/A
EBITDA 4.38B
Net income avi to common (ttm)2.95B
Diluted EPS (ttm)1.68
Quarterly earnings growth (yoy)14.20%

Balance sheet

Total cash (mrq)3.56B
Total cash per share (mrq)2.04
Total debt (mrq)1.69B
Total debt/equity (mrq)7.50%
Current ratio (mrq)1.76
Book value per share (mrq)12.55

Cash flow statement

Operating cash flow (ttm)3.69B
Levered free cash flow (ttm)1.59B